Drug
Clobetasol Propionate 0 05 Spray
Clobetasol Propionate 0 05 Spray: highest development phase Post-Market, developed by Galderma. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Galderma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Clobetasol Propionate 0.05% Spray NCT00436540 | Post-Market | Psoriasis |
Latest
No recent events.
Follow Clobetasol Propionate 0 05 Spray on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.